Patient Inquiry Information

STELLAR Brain Cancer Clinical Trial

Brain Cancer Clinical Trial: Enrollment is Now Open for Patients with Recurrent Anaplastic Astrocytoma

The STELLAR study is an investigational Phase 3 clinical trial for patients who have recurrent anaplastic astrocytoma.

A patient may qualify for this study if the patient:

·       Has anaplastic astrocytoma that has recurred following radiation therapy                and adjuvant temozolomide chemotherapy

·       Has had prior surgery, radiation and temozolomide chemotherapy

·       Is an adult over the age of 18 years old

Currently, this study is being offered at select sites in the United States, Germany and Italy. Please complete this form and a representative from an active clinical site will be in touch with you as soon as possible.

Eflornithine is an investigational product. An investigational product is one that has not been proven to be safe and effective for this use and is not licensed by the US Food and Drug Administration or any other government agency. An investigational product can only be administered in a research study.

* required information

Name *

View our Privacy Policy:


Below are links for additional patient information:



www.abta. org (American Brain Tumor Association)

theibta.o rg (International Brain Tumor Society)

http://br (National Brain Tumor Society)  (ABC2) 

raredisea (National Organization of Rare Disorders) 


Public Facebook pages:

BrainCancerMoonshot  https://www.facebook. com/groups/1202877546407969/

Hope for Grey Matters  https://www. HopeForGreyMatters/


Private Facebook pages:

Astrocytoma Brain Cancer  https://www. astrocytoma%20brain%20cancer

Anaplastic Astrocytoma  https:// q=anaplastic%20astrocytoma% 20brain%20cancer

Braintrust.o rg  http://braintrust. org/